Bio-Techne Corporation (TECH) CEO Chuck Kummeth On Q3 2022 Results - Earnings Call Transcript

Bio-Techne Corporation (NASDAQ:TECH) Q3 2022 Earnings Conference Call May 4, 2022 9:00 AM ET

Company Participants

David Clair - Senior Director, IR and Corporate Development

Chuck Kummeth - CEO

Jim Hippel - CFO

Conference Call Participants

Dan Arias - Stifel

Puneet Souda - SVB Securities

Jacob Johnson - Stephens

Alex Nowak - Craig-Hallum

Catherine Schulte - Baird

Patrick Donnelly - Citi

Paul Knight - KeyBanc

Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.

Operator

00:04 Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Third Quarter of Fiscal Year 2022. At this time, all participants have been placed in listen-only mode and the call will be opened for questions following management's prepared remarks. During our Q&A session, please limit yourself to one question and a follow-up.

00:24 I would now like to turn the call over to David Clair, Bio-Techne's Senior Director, Investor Relations and Corporate Development. Please go ahead, sir.

David Clair

00:34 Good morning, and thank you for joining us. On the call with me this morning are Chuck Kummeth, Chief Executive Officer; and Jim Hippel, Chief Financial Officer of Bio-Techne.

00:42 Before we begin, let me briefly cover our safe harbor statement. Some of the comments made during this conference call may be considered forward-looking statements, including beliefs and expectations about the company's future results, as well as the potential impact of the COVID-19 pandemic on our operations and financial results.

01:05 The company's 10-K for fiscal year 2021 identifies certain factors that could cause the company's actual results to differ materially from those projected in the forward-looking statements made during this call. The company does not undertake to update any forward-looking statements because of any new information or future events or developments. The 10-K as well as the company's other SEC filings are available on the company's website within its Investor Relations section.

01:31 During the call, non-GAAP financial measures may be used to provide information pertinent to ongoing business performance. Tables reconciling these measures to most comparable GAAP measures are available in the company's press release issued earlier this morning on the Bio-Techne Corporation website at www.bio-techne.com.